Triglav Skladi’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.9M Buy
49,909
+815
+2% +$65.7K 0.21% 73
2026
Q1
$4.25M Buy
49,094
+442
+0.9% +$42.3K 0.3% 59
2025
Q4
$4.67M Sell
48,652
-1,500
-3% -$146K 0.3% 59
2025
Q3
$4.78M Buy
50,152
+153
+0.3% +$14.1K 0.31% 56
2025
Q2
$4.36M Sell
49,999
-10,000
-17% -$848K 0.32% 58
2025
Q1
$5.39M Buy
59,999
+41,500
+224% +$3.71M 0.45% 49
2024
Q4
$1.48M Buy
+18,499
New +$1.6M 0.12% 90

Other funds holding MDT

Triglav Skladi's MDT Position: Q2 2026 in Review

Triglav Skladi increased its Medtronic (MDT) stake by 1.7% in Q2 2026, buying an estimated $65.7K and bringing the position to 49,909 shares worth $3.9M. The position accounts for 0.21% of the portfolio, ranked #73.

Triglav Skladi first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.39M in Q1 2025. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Triglav Skladi held 49,909 shares of Medtronic worth $3.9M as of Q2 2026.
  • Triglav Skladi bought 815 Medtronic shares in Q2 2026, an estimated $65.7K.
  • Medtronic made up 0.21% of Triglav Skladi's portfolio in Q2 2026, its #73 holding.
  • Triglav Skladi first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • Triglav Skladi's Medtronic position peaked at $5.39M in Q1 2025.
  • 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Triglav Skladi's 13F filing for Q2 2026, filed 11 Aug 2026.